Across Europe, the probability of receiving a timely cancer diagnosis and surviving the disease differs considerably due to inequalities in preventive policies, access to state-of-the art diagnostics, treatments and care. Therefore, the usage of tele-medicine in healthcare has now, more than ever, been acknowledged as important in responding to epidemic situations, including the COVID-19 pandemic.